title: Effects of melatonin on streptozotocin-induced diabetic liver injury in rats.
abstract: This study investigated the possible protective effects of melatonin as an antioxidant against streptozotocin (STZ)-induced diabetic liver injury in rats. Wistar rats were divided into four groups: untreated control (UC), melatonin-treated control (MC), untreated diabetic (UD), and melatonin-treated diabetic (MD). Experimental diabetes was induced by a single-dose (60 mg/kg, intraperitoneally (ip)) STZ injection, and melatonin was injected (200 microg/kg/day, ip) for 4 weeks. Upon light and electron microscopic examination, we observed that melatonin improved the morphological and histopathological changes of the liver caused by diabetes. Malondialdehyde levels in the liver homogenates of UD rats were higher than those of controls and were markedly reduced after melatonin treatment. Although no significant difference was observed with respect to antioxidant status, the superoxide dismutase activity tended to be higher in the UD rats than in the treated rats. Our findings showed that melatonin administration partially reduced liver injury in STZ-induced diabetic rats.
authors.affiliation: Department of Histology and Embryology, Abant Izzet Baysal University, Duzce School of Medicine, 81620 Konuralp, Duzce, Turkey. drayselguven@yahoo.com
authors.forename: Aysel
authors.initials: A
authors.lastname: Guven
authors.forename: Ozlem
authors.initials: O
authors.lastname: Yavuz
authors.forename: Meryem
authors.initials: M
authors.lastname: Cam
authors.forename: Feriha
authors.initials: F
authors.lastname: Ercan
authors.forename: Neslihan
authors.initials: N
authors.lastname: Bukan
authors.forename: Cem
authors.initials: C
authors.lastname: Comunoglu
authors.forename: Fatih
authors.initials: F
authors.lastname: Gokce
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use*; D001786:Blood Glucose / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D003921:Diabetes Mellitus, Experimental / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D006943:Hyperglycemia / Q000517:prevention & control; D015227:Lipid Peroxidation; D008054:Lipid Peroxides / Q000378:metabolism; D008099:Liver / Q000187:drug effects*; D008107:Liver Diseases / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism / Q000473:pathology; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D008550:Melatonin / Q000627:therapeutic use*; D008854:Microscopy, Electron; D018384:Oxidative Stress / Q000187:drug effects; D051381:Rats; D017208:Rats, Wistar; D013482:Superoxide Dismutase / Q000378:metabolism
chemical_list: D000975:Antioxidants; D001786:Blood Glucose; D008054:Lipid Peroxides; D008315:Malondialdehyde; D013482:Superoxide Dismutase; D008550:Melatonin